Ecolab Life Sciences Introduces Klercide™ Rapid Sporicide for Cleanroom Applications

New solution reduces time and costs to meet the modern demands of pharmaceutical production.

October 29, 2025
A cleanroom operator spraying KLERCIDE™ RAPID SPORICIDE onto a surface.

St. Paul, Minn. – October 29, 2025 – Ecolab Life Sciences today announced the launch of its Klercide™ Rapid Sporicide, a new sporicidal disinfectant designed to elevate pharmaceutical cleanroom safety and performance, while reducing overall production turnover time. This new pharma cleanroom product is milder on equipment and surfaces and helps improve user experience along with work conditions.

Ecolab’s latest pharma cleanroom sporicide addresses long-standing challenges in pharma microbial control, like strong odors, corrosiveness, and full surface coverage, all of which contribute to a reduced lifetime of equipment and a less desirable work environment for operators. This new formula is a market-changing innovation, delivering efficacy while minimizing residue, reducing re-application time and enhancing the overall user experience. This leads to shorter changeover times and overall savings for pharmaceutical manufacturers, helping deliver safely made medicines to patients faster. The new sporicide will be available in a variety of formats to meet the entire lifecycle of pharma production.

“Cleanroom operators and pharmaceutical manufacturers have long sought a sporicide solution that balances efficacy and usability, without the strong odor or corrosiveness associated with existing solutions,” said Meg Carr, vice president & general manager, Ecolab Life Sciences. “Klercide Rapid Sporicide represents a significant advancement in cleanroom contamination control and underpins Ecolab’s commitment to creating a measurable impact in safe manufacturing.”

Klercide Rapid Sporicide is registered with the Environmental Protection Agency (EPA Reg. No. 1677-288) for use against bacterial spores, fungi, and other hard-to-kill microorganisms. State registrations are in process.

Further information regarding the new solution can also be viewed at the Ecolab Life Sciences website here.

About Ecolab

A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, Ecolab has advanced innovation by integrating science‑based solutions, data‑driven insights, AI technology and world‑class service. This unique combination enables Ecolab to partner with customers to define what best‑in‑class looks like and scale it across their operations, helping them achieve peak performance. Today, Ecolab has $16 billion in annual sales, 48,000 associates and customers in more than 170 countries and 40 industries. The company helps protect one‑third of the world’s food production and a quarter of the power generated while delivering innovative solutions across food, healthcare, data centers, microelectronics, life sciences and hospitality. Ecolab’s comprehensive approach protects what’s vital, aiming by 2030 to help protect 2 billion people from infections and enough drinking water for 1 billion people while enhancing business performance.

www.ecolab.com

Follow us on LinkedIn @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.

Related News